Rhizen Pharmaceuticals AG

Developing The Next Generation Medicines That Will Lead The Fight Against Cancer

General Information
Company Name
Rhizen Pharmaceuticals AG
Founded Year
2012
Location (Offices)
Basel, Switzerland +1
Founders / Decision Makers
Number of Employees
5
Industries
Biotechnology, Pharmaceutical
Funding Stage
-
Social Media

Rhizen Pharmaceuticals AG - Company Profile

Rhizen Pharmaceuticals AG is a Swiss HQ biotech company that is dedicated to developing innovative, small molecule drugs for the treatment of cancer & inflammatory diseases. Its slogan, "Developing The Next Generation Medicines That Will Lead The Fight Against Cancer," reflects its commitment to creating impactful solutions. Rhizen has established itself as a leader in the PI3K space with the discovery of Umbralisib & Tenalisib - class leading PI3K isoform-specific inhibitors aimed at transforming the NHL & CLL space. Since its foundation in 2012, the company has built a deep pipeline of novel differentiated assets across various stages of development. As a player in the Biotechnology and Pharmaceutical industries, Rhizen Pharmaceuticals AG is poised for significant growth and impact in the fight against cancer and inflammatory diseases.

Taxonomy: biotech, drug discovery, small molecule drugs, cancer treatment, inflammatory diseases, PI3K inhibitors, clinical-stage biopharmaceutical, signal transduction networks, ion channels, autoimmune diseases, metabolic disorders, virtual company, out sourcing, pre-clinical development, clinical development

Funding Rounds & Investors of Rhizen Pharmaceuticals AG (0)

View All

There is no investment information

Latest News of Rhizen Pharmaceuticals AG

View All

No recent news or press coverage available for Rhizen Pharmaceuticals AG.

Similar Companies to Rhizen Pharmaceuticals AG

View All
PRAEVENTIX LLC - Similar company to Rhizen Pharmaceuticals AG
PRAEVENTIX LLC Pioneering the future of healthcare by developing innovative therapies for bowel, dermatologic, autoimmune, and neurodegenerative diseases.
NGM Biopharmaceuticals - Similar company to Rhizen Pharmaceuticals AG
NGM Biopharmaceuticals Explorers on the frontier of life-changing science.
Semafore Pharmaceuticals - Similar company to Rhizen Pharmaceuticals AG
Semafore Pharmaceuticals Pioneering the future of cancer treatment with innovative PI3K inhibitors.
TenNor Therapeutics - Similar company to Rhizen Pharmaceuticals AG
TenNor Therapeutics Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.
Flame Biosciences - Similar company to Rhizen Pharmaceuticals AG
Flame Biosciences A clinical-stage pioneer focused on discovering, developing, and commercializing groundbreaking therapies for cancer and inflammatory diseases.